Wakasa M - Search Results

1

Long-Term Effect of Denosumab on Bone Disease in Patients with CKD.

Iseri K, Mizobuchi M, Winzenrieth R, Humbert L, Saitou T, Kato T, Nakajima Y, Wakasa M, Shishido K, Honda H. Iseri K, et al. Among authors: wakasa m. Clin J Am Soc Nephrol. 2023 Sep 1;18(9):1195-1203. doi: 10.2215/CJN.0000000000000213. Epub 2023 Jun 14. Clin J Am Soc Nephrol. 2023. PMID: 37314764

2

Treatment of hyperphosphatemia with bixalomer in Japanese patients on long-term hemodialysis with gastrointestinal symptoms.

Ito K, Takeshima A, Shishido K, Wakasa M, Kumata C, Matsuzaka K, Nakajima Y, Ogata H. Ito K, et al. Among authors: wakasa m. Ther Apher Dial. 2014 Jun;18 Suppl 2:19-23. doi: 10.1111/1744-9987.12229. Ther Apher Dial. 2014. PMID: 24975891

3

Bone density of the femoral neck in patients on maintenance dialysis.

Nakanishi K, Shishido K, Kumata C, Ito K, Nakashima Y, Wakasa M. Nakanishi K, et al. Among authors: wakasa m. PLoS One. 2018 May 24;13(5):e0197965. doi: 10.1371/journal.pone.0197965. eCollection 2018. PLoS One. 2018. PMID: 29795652 Free PMC article.

4

Effect of dialysis membranes and ACE inhibitor on bradykinin levels during hemodialysis.

Akizawa T, Kinugasa E, Wakasa M, Kohjiro S, Koiwa F, Koshikawa S. Akizawa T, et al. Among authors: wakasa m. Clin Nephrol. 1994 Apr;41(4):241-4. Clin Nephrol. 1994. PMID: 8026119 Clinical Trial.

5

Randomized controlled open-label trial of vitamin E-bonded polysulfone dialyzer and erythropoiesis-stimulating agent response.

Sanaka T, Mochizuki T, Kinugasa E, Kusano E, Ohwada S, Kuno T, Kojima K, Kobayashi S, Satoh M, Shimada N, Nakao K, Nakazawa R, Nishimura H, Noiri E, Shigematsu T, Tomo T, Maeda T; VEESA Study Group. Sanaka T, et al. Clin J Am Soc Nephrol. 2013 Jun;8(6):969-78. doi: 10.2215/CJN.04680512. Epub 2013 Apr 18. Clin J Am Soc Nephrol. 2013. PMID: 23599410 Free PMC article. Clinical Trial.

6

Plasma bradykinin levels during hemodialysis with PAN DX and polysulfone membranes with and without concurrent ACE inhibitor.

Wakasa M, Akizawa T, Kinugasa E, Koshikawa S. Wakasa M, et al. Clin Nephrol. 1995 Nov;44 Suppl 1:S29-32. Clin Nephrol. 1995. PMID: 8608658 Clinical Trial.

7

Nafamostat as anti-coagulant for membrane plasmapheresis in high bleeding risk patients.

Kinugasa E, Akizawa T, Nakashima Y, Wakasa M, Koshikawa S. Kinugasa E, et al. Among authors: wakasa m. Int J Artif Organs. 1992 Oct;15(10):595-600. Int J Artif Organs. 1992. PMID: 1428207

8

Health literacy in older patients with abdominal tumours and its association with clinical characteristics: A cross-sectional study.

Iwakura M, Kawagoshi A, Furukawa Y, Sugawara K, Wakabayashi T, Sato T, Wakasa M. Iwakura M, et al. Among authors: wakasa m. Eur J Oncol Nurs. 2023 Dec;67:102461. doi: 10.1016/j.ejon.2023.102461. Epub 2023 Nov 7. Eur J Oncol Nurs. 2023. PMID: 37976753

9

Thrombotic Microangiopathy after a 15-year Treatment with Interferon Beta-1b in a Patient with Multiple Sclerosis: A Case Report and Review of Literature.

Akita S, Fujibayashi K, Ueno EI, Wakasa M, Kawai Y, Kajinami K. Akita S, et al. Among authors: wakasa m. Intern Med. 2024 Apr 15;63(8):1113-1117. doi: 10.2169/internalmedicine.1846-23. Epub 2023 Sep 1. Intern Med. 2024. PMID: 37661454 Free PMC article. Review.

10

Discharge Planning and Challenges for Patients With Asian Lifestyles Following Total Hip Arthroplasty: National Survey Design in Japan.

Makabe S, Kume Y, Akagawa Y, Wakasa M, Ito K, Kijima H. Makabe S, et al. Among authors: wakasa m. Orthop Nurs. 2023 Mar-Apr 01;42(2):115-122. doi: 10.1097/NOR.0000000000000930. Orthop Nurs. 2023. PMID: 36944207

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

79 results

Search Page